GlobalData on MSN21h
Opko and Entera focus on oral care for obesity and metabolic disordersOpko Health and Entera Bio have announced a partnership and licence agreement to progress the development of the first oral ...
Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.
On the foreign exchange market, the representative shekel-US dollar exchange rate was set 0.05% higher, at 3.6650/$, and the representative shekel-euro rate was set 0.36% higher, at 4.0073/€.
Pharma market insights provider Evaluate today released its 2025 Orphan Drug Report highlighting forecasts for the orphan drug market out to 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback